Builderflor Cushioned Vinyl Floor Covering (1978–1980) — Congoleum Corporation

Congoleum Corporation’s Builderflor cushioned vinyl was a resilient flooring product manufactured during the late 1970s that has been identified in asbestos litigation and trust fund proceedings as containing asbestos-bearing materials. Workers involved in its installation, removal, and handling during its production years face documented exposure risks, and legal remedies remain available through the Congoleum Asbestos PI Trust.

Product Description

Builderflor was a cushioned sheet vinyl floor covering manufactured by Congoleum Corporation, a major American resilient flooring producer with a long commercial history dating back to the early twentieth century. The product was sold under the Builderflor name during the period of approximately 1978 to 1980 and was designed for residential and light commercial applications where durability, comfort underfoot, and ease of maintenance were priorities.

Cushioned vinyl flooring of this era was a multi-layer product. Manufacturers such as Congoleum engineered these floors to provide resilience — a slight compressibility that reduced fatigue for people standing or walking on hard surfaces for extended periods. The cushioned construction typically incorporated a felt or fibrous backing layer, a foam or air-cell core, a vinyl wear layer, and a printed decorative surface. It was sold in roll form and installed by cutting to fit the room dimensions, then adhering to the subfloor using compatible adhesives.

Congoleum Corporation was one of the dominant flooring manufacturers in the United States during the mid-twentieth century and produced numerous sheet vinyl and tile products across multiple brand names. By the late 1970s, the company was under increasing regulatory scrutiny regarding the use of asbestos in flooring components, a scrutiny that would ultimately contribute to the asbestos personal injury litigation that led to the establishment of the Congoleum Asbestos PI Trust.

Asbestos Content

Asbestos was commonly incorporated into resilient flooring products manufactured before and during the late 1970s, and Builderflor cushioned vinyl has been identified in trust fund and litigation records as an asbestos-containing product. In flooring products of this type, asbestos was typically present in one or more structural layers. The fibrous backing layer was a frequent location for asbestos incorporation, as chrysotile asbestos fibers provided dimensional stability, resistance to moisture, and structural integrity that supported the vinyl layers above. Asbestos was also used in some formulations of the adhesive compounds recommended or supplied for installation.

The United States Environmental Protection Agency’s Asbestos Hazard Emergency Response Act (AHERA) regulations and related guidance documents have long identified resilient floor coverings, including sheet vinyl with asbestos-containing backing, as a category of asbestos-containing building material (ACBM) requiring specific management and abatement protocols. Products of this type, when intact and undisturbed, are generally considered lower-risk; however, the risk profile changes substantially when the material is cut, sanded, scraped, drilled, or subjected to aggressive removal methods.

The Occupational Safety and Health Administration (OSHA) has established specific permissible exposure limits for airborne asbestos fibers and mandates that employers assess and control asbestos exposure when workers disturb materials known or presumed to contain asbestos. Resilient flooring products manufactured prior to 1980 — the period during which Builderflor was produced — fall within the timeframe when OSHA guidance recommends presumptive treatment as asbestos-containing material absent laboratory testing confirming otherwise.

How Workers Were Exposed

Industrial workers and flooring tradespeople encountered Builderflor cushioned vinyl and comparable products across a range of job tasks during and after its production years. The exposure pathways most thoroughly documented in trust fund and litigation records include installation, maintenance, and removal activities.

Installation workers cutting sheet vinyl to size using utility knives, shears, or rotary cutters could disturb the asbestos-containing backing layer, releasing fibers into the breathing zone. Workers fitting the product around obstacles, trimming edges, or scribing cuts against walls performed repeated cutting operations over the course of a workday, potentially generating sustained fiber release.

Adhesive application presented a secondary exposure pathway. Floor adhesives of this era sometimes contained asbestos as a thickening or reinforcing agent. Workers troweling adhesive across subfloor surfaces and pressing the vinyl sheeting into contact with it may have been exposed to fibers from both the adhesive and the backing of the flooring material itself.

Removal and abatement workers faced the most intense documented exposures. When Builderflor and similar cushioned vinyl products were torn up during renovation or demolition projects, the asbestos-containing backing frequently fractured and crumbled, releasing substantial quantities of fibers. Dry scraping of residual backing and adhesive from the subfloor — a common practice before the risks were fully regulated — generated significant airborne fiber concentrations. OSHA’s resilient floor covering removal standards specifically address these hazards, requiring wet methods, HEPA vacuuming, and appropriate respiratory protection.

General industrial workers present in facilities where this flooring was installed may also have been exposed secondentially during maintenance activities, particularly in settings where floor surfaces were subjected to heavy traffic, grinding, or mechanical wear that could erode the wearing layers and expose the backing.

Because many workers in the flooring trades moved between job sites and handled multiple products in the course of their careers, individual exposure histories often involved Builderflor alongside other asbestos-containing flooring, adhesive, and underlayment products.

Congoleum Corporation filed for Chapter 11 bankruptcy protection in 2003, in significant part due to the volume of asbestos personal injury claims filed against it. As part of the bankruptcy reorganization process, the Congoleum Asbestos PI Trust was established to compensate individuals who suffered injuries as a result of exposure to asbestos-containing products manufactured or distributed by Congoleum Corporation, including Builderflor cushioned vinyl.

The Congoleum Asbestos PI Trust operates under a Trust Distribution Procedures (TDP) document that defines eligibility criteria, claim categories, and compensation structures. Claimants seeking compensation through the Trust must demonstrate an exposure history to a qualifying Congoleum product, a diagnosed asbestos-related disease, and a medical and occupational history consistent with Trust requirements.

Qualifying disease categories recognized in asbestos trust fund proceedings of this type typically include:

  • Mesothelioma — malignant mesothelioma of the pleura, peritoneum, or pericardium
  • Lung cancer — primary lung cancer with documented asbestos exposure history
  • Other cancers — certain asbestos-related cancers as defined in the TDP
  • Asbestosis — pulmonary fibrosis resulting from asbestos fiber inhalation, supported by pulmonary function testing and imaging
  • Other non-malignant conditions — pleural plaques, pleural thickening, and pleural effusion meeting Trust diagnostic criteria

Builderflor cushioned vinyl is among the Congoleum products that may be named directly in Trust submissions. Workers with documented or reconstructed exposure to this specific product during its 1978–1980 production and subsequent installation and removal years may be eligible to file.

Individuals who believe they were exposed to Builderflor or other Congoleum asbestos-containing flooring products should consult with an attorney experienced in asbestos trust fund claims. Trust fund filings are separate from civil litigation, and in many cases claimants may pursue both simultaneously, depending on the facts of their case and the defendants involved.